Large Trial Demonstrates Short-Term Safety Of Bariatric Surgery
This article was originally published in The Gray Sheet
Executive Summary
Bariatric surgery is associated with a relatively low risk of major adverse events in the first 30 days following the procedure, researchers report in the July 30 New England Journal of Medicine
You may also be interested in...
Bariatric Surgeries Prolong Life, According To Studies In NEJM
Two new studies show that bariatric surgery results in significantly greater long-term weight loss and lower mortality than medical management or no treatment, suggesting that patients and physicians should consider early surgical intervention to treat morbid obesity
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.